특발성 저신장증 환아의 혈중 Insulin-like Growth Factor-I 및 Insulin-like Growth Factor Binding Protein-3 농도
Serum Levels of Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 in Children with Idiopathic Short Stature
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose : The aim of present study was to compare the mean serum levels of Insulin-like growth factor-I (IGF-I) and Insulin-like growth factor binding protein-3 (IGFBP-3) according to the Korean standard growth chart especially in children with idiopathic short stature. Methods : Serum levels of IGF-I and IGFBP-3 were determined in 454 children (252 boys and 202 girls; ages 7-15 yr), grouped into two, according to their height below 10 percentile (idiopathic short stature) and 25-50 percentile based on growth chart- 1998 reported by Korean Society of Pediatrics. Serum levels of IGF-I were measured by RIA method and serum levels of IGFBP-3 were measured by IRMA method. Results : Mean serum levels of IGF-I and IGFBP-3 were lower in below 10 percentile group compared with those of 25-50 percentile group in both sexes. In some age groups, the differences between two groups revealed statistical significance. The difference of serum levels according to growth channel showed more prominence in IGF-I compared than IGFBP-3. Significant statistical correlations were demonstrated in all study groups between serum IGF-I and IGFBP-3 levels according to the age, respectively. Conclusion : Our results strongly suggest that mean serum levels of IGF-I and IGFBP-3 in children with idiopathic short stature were lower than those of control group.
Abstract
Purpose : The aim of present study was to compare the mean serum levels of Insulin-like growth factor-I (IGF-I) and Insulin-like growth factor binding protein-3 (IGFBP-3) according to the Korean standard growth chart especially in children with idiopathic short stature. Methods : Serum levels of IGF-I and IGFBP-3 were determined in 454 children (252 boys and 202 girls; ages 7-15 yr), grouped into two, according to their height below 10 percentile (idiopathic short stature) and 25-50 percentile based on growth chart- 1998 reported by Korean Society of Pediatrics. Serum levels of IGF-I were measured by RIA method and serum levels of IGFBP-3 were measured by IRMA method. Results : Mean serum levels of IGF-I and IGFBP-3 were lower in below 10 percentile group compared with those of 25-50 percentile group in both sexes. In some age groups, the differences between two groups revealed statistical significance. The difference of serum levels according to growth channel showed more prominence in IGF-I compared than IGFBP-3. Significant statistical correlations were demonstrated in all study groups between serum IGF-I and IGFBP-3 levels according to the age, respectively. Conclusion : Our results strongly suggest that mean serum levels of IGF-I and IGFBP-3 in children with idiopathic short stature were lower than those of control group.
참고문헌 (24)
- Juul A., "Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation", J Clin Endocrinol Metab, 80, pp.2534~2542 (1995)
- Jorgensen J.O., "Circadian patterns of serum insulin-like growth factor (IGF) II and IGF binding protein 3 in growth hormone-deficient patients and age- and sex- matched normal subjects", Acta Endocrinol (Copenh), 123, pp.257~262 (1990)
- Rinderknecht E., "The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin", J Biol Chem, 253, pp.2769~2776 (1978)
- Guler H.P., "Insulin- like growth factors I and II in healthy man. Estimations of half-lives and production rates", Acta Endocrinol. (Copenh), 121, pp.753~758 (1989)
- Boxter R.C., "Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma", J Clin Endocrinol Metab, 65, pp.432~440 (1987)
- Boxter R.C., "Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma", L Clin Invest, 78, pp.1504~1512 (1986)
- Blum W.F., "A lbertsson-Wikland K, Rosberg S, Rank MB. Serum levels of insulin-like growth-factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion", J Clin Endocrinol Metab, 76, pp.1610~1616 (1993)
- Hasegawa Y., "Western ligand blot assay for human growth hormone-dependent insulin-like growth factor binding protein (IGFBP-3): the serum levels in patients with classical growth hormone deficiency", Endocrinol Jpn, 39, pp.121~127 (1992)
- Smith W.J., "Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-Ifor assessing growth hormone status in short children", J Clin Endocrinol Metab, 77, pp.1294~1299 (1993)
- Hasegawa Y., "Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency", Eur J Endocrinol, 131, pp.27~32 (1994)
- Juul A., "Serum insulin-like growth factor-1 in 1030 healthy children, adolescents and adults; relation to age, sex, stage of puberty, testicular size and body mass index", J Clin Endocrinol Metab, 78, pp.744~752 (1994)
- Rosenfield R.I., "Relationship of somatomedin-C concentration to pubertal changes", J Pediatr, 103, pp.723~728 (1983)
- Lee P.D., "Rosenfield RG. Efficacy of insulin-like growth factor I levels in predicting the response to provocative growth hormone testing", Pediatr Res, 27, pp.45~51 (1990)
- Kim K.J., "The diagnostic utility of insulin- like growth factor binding protein-3 (IGFBP-3) in growht hormone deficiency and comparison with insulin-like growth factor-I (IGF-I)", J Korean Soc Pediatr Endocrinol, 5, pp.35~44 (2000)
- Blair J.C., "Standard and low dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature", Clinical Endocrinology (Oxf), 60, pp.163~168 (2004)
- Attie K.M., "Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The national cooperative growth study", J Pediatrics, 127, pp.244~250 (1995)
- Kamoda T., "Serum levels of free insulin-like growth factor (IGF)-I and IGF-binding protein-1 in prepubertal children with idiopathic short stature", Clinical Endocrinology, 53, pp.683~688 (2000)
- Lindgren B.F., "Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability", Growth Reg, 6, pp.158~164 (1996)
- Dos Santos C., "A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone", Nat Genet, 36, pp.721~724 (2004)
- Goddard A.D., "Mutations of the growth hormone receptor in children with idiopathic short stature", N Engl J Med, 333, pp.1093~1098 (1995)
- Kofoed E.M., "Groewth hormone insensitivity associated with STAT5b mutation", N Engl J Med, 349, pp.1134~1137 (2003)
- Milward A., "Growth hormone insensitivity syndrome due to a GH receptor truncated after B0x 1, resulting in isolated failure of STAT 5 signaling transduction", J Clin Endocrinol Metab, 89, pp.1259~1266 (2004)
- Chung W.Y., "The concentration of insulin like growth factor-I (IGF-I) and IGF-I binding protein-3 (IGFBP-3) in the serum of children with growth hormone deficiency and the alterations after growth hormone treatment", J Korean Pediatr Soc, 39, pp.846~855 (1996)
- Park P., "Insulin-like growth factor I (IGF- I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS)", Growth Hormone & IGF-I Res, 205(15), pp.S13~S20
